---
title: "Bacitracin Ophthalmic Ointment Shortage: Supply Issues Reported Due to Manufacturing Discontinuation"
summary: "Bacitracin Ophthalmic Ointment is currently unavailable from major suppliers due to manufacturing discontinuation, with shortages expected to persist for up to 20 months."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Bacitracin","Ophthalmic-Ointment"]
location: "United States"
severity: "high"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-12T14:42:29.000Z
---
### What's in Shortage
Bacitracin Ophthalmic Ointment (Brand Name: BACITRACIN) is currently listed in a shortage status. This medication is classified under the therapeutic categories of Anti-Infective and Ophthalmology and is administered as an ophthalmic ointment.

### Which Manufacturers Are Affected
The following manufacturer is currently impacted:

*   **Padagis US LLC**
    *   **Status**: Unavailable
    *   **Presentation**: Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)
    *   **Notes**: The shortage for this product is estimated to last for approximately 20 months.
    *   **Contact Information**: 866-634-9120

### Why There's a Shortage
The current shortage is attributed to the discontinuation of the manufacture of the drug. 

### What Patients Should Do
Patients who rely on Bacitracin Ophthalmic Ointment should take the following steps:
1. **Consult Your Healthcare Provider**: Speak with your doctor or ophthalmologist to discuss the shortage and determine the best course of action for your specific medical needs.
2. **Talk to Your Pharmacist**: Your pharmacist can provide information on current local availability or help coordinate with your physician regarding alternatives.
3. **Contact the Manufacturer**: For specific questions regarding supply timelines, you may contact Padagis US LLC at the number provided above.

*Disclaimer: This article is for informational purposes only. Patients should always consult their healthcare provider for medical advice, diagnosis, or treatment options regarding medication changes.*

### Source
Information provided by the FDA Drug Shortage Database.
*   **Initial Posting Date**: 03/03/2025
*   **Last Updated**: 02/04/2026